LabCorp is Scheduled to Present at the Barclays Capital 2015 Global Healthcare Conference Read more about LabCorp is Scheduled to Present at the Barclays Capital 2015 Global Healthcare Conference
Laboratory Corporation of America® Holdings Announces 2014 Fourth Quarter and Full Year Results and Provides 2015 Guidance Read more about Laboratory Corporation of America® Holdings Announces 2014 Fourth Quarter and Full Year Results and Provides 2015 Guidance
LabCorp Launches New Patient-Centric Diabetes Report Read more about LabCorp Launches New Patient-Centric Diabetes Report
LabCorp Prices $500,000,000 in 2.625% Senior Notes Due 2020, $500,000,000 in 3.200% Senior Notes Due 2022, $1,000,000,000 in 3.600% Senior Notes Due 2025 and $900,000,000 in 4.700% Senior Notes Due 2045 Read more about LabCorp Prices $500,000,000 in 2.625% Senior Notes Due 2020, $500,000,000 in 3.200% Senior Notes Due 2022, $1,000,000,000 in 3.600% Senior Notes Due 2025 and $900,000,000 in 4.700% Senior Notes Due 2045
LabCorp Announces Proposed Sale of Senior Notes Read more about LabCorp Announces Proposed Sale of Senior Notes
LabCorp is Scheduled to Present at the 33rd Annual J.P. Morgan Healthcare Conference Read more about LabCorp is Scheduled to Present at the 33rd Annual J.P. Morgan Healthcare Conference
Conversion Right Triggered for LabCorp’s Zero Coupon Convertible Subordinated Notes Due 2021 Read more about Conversion Right Triggered for LabCorp’s Zero Coupon Convertible Subordinated Notes Due 2021
LabCorp Introduces a Test to Identify Enterovirus D-68 (EV-D68) Read more about LabCorp Introduces a Test to Identify Enterovirus D-68 (EV-D68)
LabCorp Named Laboratory Service Provider of the Pro Football Legends Read more about LabCorp Named Laboratory Service Provider of the Pro Football Legends
